Exchange: NASDAQ·Updated 03:33 PM EST

About TECX

About

Tectonic Therapeutic, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of therapeutic proteins and antibodies that modulate the activity of G protein-coupled receptors (GPCR). It develops a proprietary technology platform called GEODe to enable the discovery and development of GPCR-targeted biologic medicines. The company was founded by Timothy A. Springer and Andrew Kruse in November 2015 and is headquartered in Watertown, MA.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
60

Frequently Asked Questions

Advertisement|Remove ads.